Preferred Label : eicosapentaenoic acid;
MeSH definition : Important polyunsaturated fatty acid found in fish oils. It serves as the precursor
for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic
acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders,
prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2
and prostaglandin-2 families.;
MeSH synonym : omega-3-eicosapentaenoic acid; timnodonic acid; omega 3 eicosapentaenoic acid; 5,8,11,14,17-icosapentaenoic acid; eicosapentanoic acid; acid, eicosapentanoic; 5,8,11,14,17-Eicosapentaenoic Acid; Icosapent;
MeSH CAS label : 5,8,11,14,17-Eicosapentaenoic acid;
MeSH Related Number : 1553-41-9 (Eicosapentaenoic acid);
Registry Number MeSH : 1553-41-9;
Wikipedia link : https://en.wikipedia.org/wiki/Eicosapentaenoic acid;
Is substance : O;
UNII : AAN7QOV9EA;
InChIKey : JAZBEHYOTPTENJ-JLNKQSITSA-N;
Origin ID : D015118;
UMLS CUI : C0000545;
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Record concept(s)
Related MeSH Supplementary Concept(s)
- CLX-103 [MeSH Supplementary Concept]
- EFF1009 [MeSH Supplementary Concept]
- MAT9001 [MeSH Supplementary Concept]
- Maxepa [MeSH Supplementary Concept]
- Omacor [MeSH Supplementary Concept]
- TAK-085 [MeSH Supplementary Concept]
- TP-252 [MeSH Supplementary Concept]
- purepa [MeSH Supplementary Concept]
- so 1129 [MeSH Supplementary Concept]
- so 5407 [MeSH Supplementary Concept]
Semantic type(s)
UMLS correspondences (same concept)
Important polyunsaturated fatty acid found in fish oils. It serves as the precursor
for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic
acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders,
prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2
and prostaglandin-2 families.
https://www.ema.europa.eu/en/medicines/human/EPAR/vazkepa
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
eicosapentaenoic acid ethyl ester
eicosapentaenoic acid ethyl ester
eicosapentaenoic acid
omega-3-triglycerides incl. other esters and acids
cardiovascular diseases
adult
administration, oral
lipid regulating agents
lipid regulating agents
risk factors
hypertriglyceridemia
drug therapy, combination
hydroxymethylglutaryl-coa reductase inhibitors
pregnancy
breast feeding
dyslipidemias
drug evaluation, preclinical
---
http://www.cochrane.org/fr/CD004597
http://www.cochrane.org/fr/CD004597/utiliser-un-acide-gras-omega-3-fabrique-a-partir-dhuile-de-poisson-pour-traiter-la-perte-de-poids-liee-au-cancer
2016
false
true
false
United Kingdom
France
treatment outcome
eicosapentaenoic acid
Cancer cachexia
neoplasms
meta-analysis
french abstract
cachexia
eicosapentaenoic acid
---
http://www.has-sante.fr/portail/jcms/c_1774141/fr/omacor
2014
false
France
French
drug combinations
docosahexaenoic acids
Omacor
eicosapentaenoic acid
omega-3-triglycerides incl. other esters and acids
insurance, health, reimbursement
hypertriglyceridemia
adult
myocardial infarction
treatment outcome
drug therapy, combination
alpha-Tocopherol
evaluation of the transparency committee
drug combinations
---
http://www.has-sante.fr/portail/jcms/c_874855/omacor
http://www.has-sante.fr/portail/jcms/c_1670229/fr/omacor
http://www.has-sante.fr/portail/jcms/c_1670564/fr/omacor-02102013-avis-ct12601
http://www.has-sante.fr/portail/display.jsp?id=c_399447
2013
false
France
French
guidelines for drug use
drug combinations
docosahexaenoic acids
Omacor
eicosapentaenoic acid
omega-3-triglycerides incl. other esters and acids
insurance, health, reimbursement
hypertriglyceridemia
adult
myocardial infarction
treatment outcome
drug therapy, combination
alpha-Tocopherol
evaluation of the transparency committee
---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F36F02D
2009
false
Belgium
French
Dutch
Rosuvastatin Calcium
heart failure
chronic disease
heart failure
eicosapentaenoic acid
hospitalization
randomized controlled trials as topic
treatment outcome
docosahexaenoic acids
rosuvastatin
journal article
drug information
---